{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:37Z","timestamp":1740185017474,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00292-024-01335-4","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:02:14Z","timestamp":1717088534000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nachahmerl\u00e4sionen\/diagnostische Fallstricke des Harnblasenkarzinoms","Mimickers and diagnostic pitfalls of urinary bladder cancer"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2414-7889","authenticated-orcid":false,"given":"K.","family":"Lindemann-Docter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. T.","family":"Gaisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/path.5390","volume":"250","author":"N Almassi","year":"2020","unstructured":"Almassi\u00a0N, Pietzak\u00a0EJ, Sarungbahm\u00a0J (2020) Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities. J\u00a0Pathol 250:464\u2013465","journal-title":"J Pathol"},{"issue":"8","key":"1335_CR2","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","volume":"38","author":"MB Amin","year":"2014","unstructured":"Amin\u00a0MB, Trpkov\u00a0K, Lopez-Beltran\u00a0A, Grignon\u00a0D, Members of the ISUP, Immunohistochemistry in Diagnostic Urologic Pathology Group (2014) Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 38(8):e20\u201334","journal-title":"Am J Surg Pathol"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/his.14206","volume":"77","author":"S Bertz","year":"2020","unstructured":"Bertz\u00a0S, St\u00f6hr\u00a0R, Gaisa\u00a0NT, Wulich\u00a0B, Hartmann\u00a0A, Agaimy\u00a0A (2020) A TERT promotor mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder. Histopathology 77:949\u2013962","journal-title":"Histopathology"},{"issue":"11","key":"1335_CR4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1097\/PAS.0000000000000922","volume":"41","author":"WM Borhan","year":"2017","unstructured":"Borhan\u00a0WM, Cimino-Mathews\u00a0AM, Montgomery\u00a0EA, Epstein\u00a0JI (2017) Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Am J Surg Pathol 41(11):1570\u20131575","journal-title":"Am J Surg Pathol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.humpath.2022.06.005","volume":"133","author":"L Cheng","year":"2023","unstructured":"Cheng\u00a0L, Zhang\u00a0S, Wang\u00a0M, Lopez-Beltran\u00a0A (2023) Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management. Hum Pathol 133:56\u201375","journal-title":"Hum Pathol"},{"issue":"9","key":"1335_CR6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/PAS.0b013e318222a653","volume":"35","author":"R Cox","year":"2011","unstructured":"Cox\u00a0R, Epstein\u00a0JI (2011) Large nested variant of urothelial carcinoma: 23\u00a0cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Am J Surg Pathol 35(9):1337\u20131342","journal-title":"Am J Surg Pathol"},{"key":"1335_CR7","volume-title":"Biopsy interpretation of the Bladder","author":"JI Epstein","year":"2010","unstructured":"Epstein\u00a0JI, Reuter\u00a0VE, Amin\u00a0MB (2010) Biopsy interpretation of the Bladder, 2.\u00a0Aufl. Lippincott Publications, Philadelphia (978-1-60547-335-2)","edition":"2"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00428-013-1497-y","volume":"436","author":"JI Lopez","year":"2013","unstructured":"Lopez\u00a0JI, Schiavco-Lena\u00a0M, Corominas-Sishek\u00a0A, Yague\u00a0A, Bauleth\u00a0K (2013) Nephrogenic adenoma of the urinary tract: Clinical, histological, and immunohistochemical characteristics. Virchows Arch 436:819\u2013825","journal-title":"Virchows Arch"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2018.09.012","volume":"38","author":"ON Kryvenko","year":"2019","unstructured":"Kryvenko\u00a0ON, Epstein\u00a0JI (2019) Mimickers of urothelial neoplasia. Ann Diagn Pathol 38:11\u201319","journal-title":"Ann Diagn Pathol"},{"key":"1335_CR10","unstructured":"Sharifai N, Abro B, Chen JF, Zhao M, He H, Cao D (2020) Napsin A is a\u00a0highly sensitive marker for nepgrogenic adenoma: an immunohistochemical study with specificity test in genitourinary tumors. Hum Pathol 16: (S0046\u20138177(20)30106-4)"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/modpathol.2013.76","volume":"26","author":"JS So","year":"2013","unstructured":"So\u00a0JS, Epstein\u00a0JI (2013) GATA3 expression in paragangliomas: a\u00a0pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol 26:1365\u20131370","journal-title":"Mod Pathol"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"2940496","DOI":"10.1155\/2016\/2940496","volume":"2016","author":"S Tajima","year":"2016","unstructured":"Tajima\u00a0S, Koda\u00a0K (2016) Uroplakin II Expression in Breast Carcinomas Showing Apocrine Differentiation: Putting Some Emphasis on Invasive Pleomorphic Lobular Carcinoma as a\u00a0Potential Mimic of Urothelial Carcinoma at Metastatic Sites. Dis Markers 2016:2940496","journal-title":"Dis Markers"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41379-020-0453-z","volume":"33","author":"AS Taylor","year":"2020","unstructured":"Taylor\u00a0AS, McKenney\u00a0JK, Osunkoya\u00a0AO, Chan\u00a0MP, Al-Ahmadie\u00a0HA, Spratt\u00a0DE, Fullen\u00a0DR, Chinnaiyan\u00a0AM, Brown\u00a0NA, Mehra\u00a0R (2020) PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a\u00a0clinicopathologic study with immunohistochemical and molecular correlates. Mod Pathol 33:1165\u20131117","journal-title":"Mod Pathol"},{"key":"1335_CR14","volume-title":"WHO Classification Tumours of the Urinary System and Male Genital Organs","year":"2022","unstructured":"Tsuzuki\u00a0T (Hrsg) (2022) WHO Classification Tumours of the Urinary System and Male Genital Organs, 5.\u00a0Aufl. IARC, Lyon (978-92-832-4512-4)","edition":"5"},{"issue":"9","key":"1335_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/00000478-200309000-00008","volume":"27","author":"KE Volmar","year":"2003","unstructured":"Volmar\u00a0KE, Chan\u00a0TY, De Marzo\u00a0AM, Epstein\u00a0JI (2003) Florid von Brunn Nests Mimicking Urothelial Carcinoma. Am J Surg Pathol 27(9):1243\u20131252","journal-title":"Am J Surg Pathol"},{"key":"1335_CR16","doi-asserted-by":"crossref","unstructured":"Williamson SR, Lopez-Beltran R, Montironi R, Cheng L (2010) Glandular lesions of the urinary bladder: clinical significance and differential diagnosis. Histopathology: 1\u201324","DOI":"10.1111\/j.1365-2559.2010.03651.x"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-014-0047-7","volume":"7","author":"X Zheng","year":"2014","unstructured":"Zheng\u00a0X, Zhuge\u00a0J, Bezerra\u00a0SM, Faraj\u00a0SF, Munari\u00a0E, Fallon\u00a0JT 3rd, Yang\u00a0XJ, Argani\u00a0P, Netto\u00a0GJ, Zhong\u00a0M (2014) High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J\u00a0Hematol Oncol 7:47","journal-title":"J Hematol Oncol"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/PAS.0000000000000305","volume":"39","author":"M Zhong","year":"2015","unstructured":"Zhong\u00a0M, Tian\u00a0W, Zhuge\u00a0J, Zheng\u00a0X, Huang\u00a0T, Cai\u00a0D, Zhang\u00a0D, Yang\u00a0XJ, Argani\u00a0P, Fallon\u00a0JT, Epstein\u00a0JI (2015) Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT pomoter mutation. Am J Surg Pathol 39:127\u2013131","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1335_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5858\/arpa.2012-0076-RA","volume":"137","author":"M Zhong","year":"2013","unstructured":"Zhong\u00a0M, Gersbach\u00a0E, Rohan\u00a0SM, Yang\u00a0XJ (2013) Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 137(3):371\u2013381","journal-title":"Arch Pathol Lab Med"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00000478-200401000-00011","volume":"28","author":"M Zhou","year":"2004","unstructured":"Zhou\u00a0M, Epstein\u00a0JI, Young\u00a0RH (2004) Paraganglioma of the Urinary Bladder. A\u00a0lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol 28:94\u2013100","journal-title":"Am J Surg Pathol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-024-01335-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-024-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T09:57:59Z","timestamp":1729850279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-024-01335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1007\/s00292-024-01335-4","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"3 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Lindemann-Docter gibt an, dass kein Interessenkonflikt besteht. N.T.\u00a0Gaisa: Forschungsunterst\u00fctzung durch Janssen-Cilag, Beratert\u00e4tigkeit f\u00fcr Janssen-Cilag, Vertragshonorare AstraZeneca und BMS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}